Physicians' Academy for Cardiovascular Education

Hypertrophic cardiomyopathy: What are the concerns?

10' education - Sep. 14, 2023 - Antonis Pantazis, MD – London, UK

Video navigation menu

  • Background of HCM 00:21
  • Concerns among patients 02:40
  • Concerns among healthcare professionals 07:02
  • Take-home message 09:32

As a healthcare professional, what concerns you the most about hypertrophic cardiomyopathy (HCM)?

  • A. How to diagnose HCM.
  • B. How to prevent the risk of SCD and/or thromboembolism.
  • C. How to manage HCM.


Show transcript

Educational information

This lecture by Antonis Pantazis, MD was part of the EBAC-accredited symposium "Seeing the forest through the trees - Diagnosing and treating hypertrophic cardiomyopathy" held at the ESC Congress 2023, Amsterdam, The Netherlands.


Antonis Pantazis is a Consultant Cardiologist and Clinical Lead for the Cardiomyopathy and the Inherited Cardiovascular Conditions Service at the Royal Brompton and Harefield Hospitals in London, UK. He also is the Chairman of the nucleus of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, and leads a program for the management of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Cytokinetics.

Watch the other videos of this series

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: